» Articles » PMID: 25307510

Correlation of PROMIS Scales and Clinical Measures Among Chronic Obstructive Pulmonary Disease Patients with and Without Exacerbations

Overview
Journal Qual Life Res
Date 2014 Oct 14
PMID 25307510
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The Patient-Reported Outcomes Measurement Information System (PROMIS(®)) initiative was developed to advance the methodology of PROs applicable to chronic diseases. Chronic obstructive pulmonary disease (COPD) is a progressive chronic disease associated with poor health. This study was designed to examine the correlation of PROMIS health-related quality of life (HRQOL) scales and clinical measures among COPD patients.

Methods: A cross-sectional analysis was conducted comparing patients who were stable (n = 100) with those currently experiencing a COPD exacerbation (n = 85). All PROMIS measures for adults available at the time of the study (2008), disease-targeted and other HRQOL instruments, health literacy, percent predicted FEV1, and a 6-min walk distance were assessed when patients were considered clinically stable.

Results: Stable COPD patients reported significantly (p ≤ 0.05) better health-related quality of life on PROMIS domains than patients experiencing an exacerbation. PROMIS domain scores were significantly (p ≤ 0.01) correlated with each of legacy measures. Six-min walk scores were most highly correlated with the PROMIS physical function domain scores (r = 0.53) followed by the fatigue (r = -0.26), social (r = 0.24) and to a lesser extent depression (r = -0.23), and anxiety (r = -0.22) domain scores. Percent predicted FEV1 score was significantly associated with PROMIS physical function scores (r = 0.27).

Conclusion: This study provides support for the validity of the PROMIS measures in COPD patients.

Citing Articles

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Jayavelu N, Samaha H, Wimalasena S, Hoch A, Gygi J, Gabernet G medRxiv. 2025; .

PMID: 39990570 PMC: 11844586. DOI: 10.1101/2025.02.12.25322164.


Healthy at Home for COPD: An Integrated Digital Monitoring, Treatment, and Pulmonary Rehabilitation Intervention.

OConnor L, Behar S, Tarrant S, Stamegna P, Pretz C, Shirshac J Res Sq. 2024; .

PMID: 39606445 PMC: 11601823. DOI: 10.21203/rs.3.rs-5084150/v1.


Rationale and design of healthy at home for COPD: an integrated remote patient monitoring and virtual pulmonary rehabilitation pilot study.

OConnor L, Behar S, Tarrant S, Stamegna P, Pretz C, Wang B Pilot Feasibility Stud. 2024; 10(1):131.

PMID: 39468649 PMC: 11520050. DOI: 10.1186/s40814-024-01560-x.


Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.

Ozonoff A, Jayavelu N, Liu S, Melamed E, Milliren C, Qi J Nat Commun. 2024; 15(1):216.

PMID: 38172101 PMC: 10764789. DOI: 10.1038/s41467-023-44090-5.


Relationship Between Tobacco Product Use and Health-Related Quality of Life Among Individuals With COPD in Waves 1-5 (2013-2019) of the Population Assessment of Tobacco and Health Study.

Paulin L, Halenar M, Edwards K, Lauten K, Taylor K, Brunette M Chronic Obstr Pulm Dis. 2023; 11(1):68-82.

PMID: 38113525 PMC: 10913919. DOI: 10.15326/jcopdf.2023.0422.


References
1.
Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

2.
Yohannes A, Roomi J, Baldwin R, Connolly M . Depression in elderly outpatients with disabling chronic obstructive pulmonary disease. Age Ageing. 2005; 27(2):155-60. DOI: 10.1093/ageing/27.2.155. View

3.
Hinchcliff M, Beaumont J, Thavarajah K, Varga J, Chung A, Podlusky S . Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form. Arthritis Care Res (Hoboken). 2011; 63(11):1620-8. PMC: 3205420. DOI: 10.1002/acr.20591. View

4.
Rabe K, Hurd S, Anzueto A, Barnes P, Buist S, Calverley P . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6):532-55. DOI: 10.1164/rccm.200703-456SO. View

5.
Rothrock N, Hays R, Spritzer K, Yount S, Riley W, Cella D . Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2010; 63(11):1195-204. PMC: 2943571. DOI: 10.1016/j.jclinepi.2010.04.012. View